Xu Zhu

2.0k total citations · 1 hit paper
75 papers, 876 citations indexed

About

Xu Zhu is a scholar working on Hepatology, Surgery and Oncology. According to data from OpenAlex, Xu Zhu has authored 75 papers receiving a total of 876 indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Hepatology, 29 papers in Surgery and 25 papers in Oncology. Recurrent topics in Xu Zhu's work include Hepatocellular Carcinoma Treatment and Prognosis (43 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (21 papers) and Cancer Mechanisms and Therapy (9 papers). Xu Zhu is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (43 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (21 papers) and Cancer Mechanisms and Therapy (9 papers). Xu Zhu collaborates with scholars based in China, Ethiopia and United States. Xu Zhu's co-authors include Renjie Yang, Guang Cao, Hui Chen, Baocai Xing, Xiaodong Wang, Peng Liu, Kun Wang, Hongwei Wang, Xiaodong Wang and Haifeng Xu and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Xu Zhu

71 papers receiving 869 citations

Hit Papers

Sorafenib Plus Hepatic Arterial Infusion Chemotherapy ver... 2022 2026 2023 2024 2022 25 50 75 100
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Sorafenib Plus Hepatic Arterial Infusion Chemotherapy versus Sorafenib for Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombosis: A Randomized Trial
    2022 101 citations Xu Zhu, Guang Cao et al. Radiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xu Zhu China 18 469 257 246 203 160 75 876
Xu-Dong Qu China 16 501 1.1× 240 0.9× 203 0.8× 124 0.6× 156 1.0× 40 839
Hirofumi Kamachi Japan 18 623 1.3× 436 1.7× 218 0.9× 108 0.5× 142 0.9× 51 932
Maria Augusta Cipriano Portugal 15 213 0.5× 319 1.2× 171 0.7× 109 0.5× 180 1.1× 73 866
Weiqi Rong China 18 490 1.0× 286 1.1× 234 1.0× 62 0.3× 122 0.8× 74 802
Yuji Eso Japan 17 382 0.8× 132 0.5× 292 1.2× 117 0.6× 126 0.8× 52 806
Liming Wang China 15 292 0.6× 252 1.0× 197 0.8× 90 0.4× 121 0.8× 62 663
Kinya Okamoto Japan 19 443 0.9× 201 0.8× 182 0.7× 98 0.5× 99 0.6× 47 1.0k
Chiara Caparello Italy 15 291 0.6× 244 0.9× 569 2.3× 196 1.0× 305 1.9× 45 1.2k
Xavier Adhoute France 17 784 1.7× 199 0.8× 188 0.8× 112 0.6× 127 0.8× 52 1.2k

Countries citing papers authored by Xu Zhu

Since Specialization
Citations

This map shows the geographic impact of Xu Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xu Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xu Zhu more than expected).

Fields of papers citing papers by Xu Zhu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xu Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xu Zhu. The network helps show where Xu Zhu may publish in the future.

Co-authorship network of co-authors of Xu Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Xu Zhu. A scholar is included among the top collaborators of Xu Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xu Zhu. Xu Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhu, Xu, Zeyang Yang, Xuanyin Wang, et al.. (2025). CAFs mediate carboplatin resistance in LUAD via CXCL12 secretion regulated by NF-κB activation. Cellular Oncology. 48(6). 1775–1794.
2.
Yang, Zeyang, Xuanyin Wang, Xu Zhu, et al.. (2025). CD248 induces PD-L1 expression on cancer-associated fibroblasts to promote NSCLC immune escape. Frontiers in Cell and Developmental Biology. 13. 1635915–1635915. 3 indexed citations
3.
Li, Hui, et al.. (2024). Integrated multi-omics demonstrates enhanced antitumor efficacy of donafenib combined with FADS2 inhibition in hepatocellular carcinoma. Translational Oncology. 51. 102142–102142. 1 indexed citations
4.
Zhu, Xu, et al.. (2024). Multi-scale topology optimisation design and mechanical property analysis of porous interbody fusion cage. Bio-Medical Materials and Engineering. 36(2). 110–123. 1 indexed citations
5.
Zhang, Xin, Xiaodong Wang, Hui Chen, et al.. (2023). Efficacy and safety of irinotecan-eluting HepaSphere transarterial chemoembolization combined with hepatic arterial infusion chemotherapy for unresectable colorectal liver metastases.. Journal of Clinical Oncology. 41(16_suppl). 3585–3585. 1 indexed citations
6.
Meng, Qinghua, Zhenyu Zhu, Juan Li, et al.. (2023). Chinese expert consensus on the overall management of liver function in conversion therapy for liver cancer (2022 edition). Chinese Medical Journal. 136(24). 2909–2911. 1 indexed citations
7.
Zhang, Xin, Xiaodong Wang, Guang Cao, et al.. (2023). A Novel Nomogram for Predicting the Overall Survival in Patients with Unresectable HCC after TACE plus Hepatic Arterial Infusion Chemotherapy. Translational Oncology. 34. 101705–101705. 8 indexed citations
8.
Shao, Guoliang, Xu Zhu, Weijia Fang, et al.. (2022). Phase 2 Study of the PD-1 Inhibitor Serplulimab plus the Bevacizumab Biosimilar HLX04 in Patients with Previously Treated Advanced Hepatocellular Carcinoma. Liver Cancer. 12(2). 116–128. 7 indexed citations
9.
Zhu, Xu, Guang Cao, Wenqing Li, et al.. (2022). Sorafenib Plus Hepatic Arterial Infusion Chemotherapy versus Sorafenib for Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombosis: A Randomized Trial. Radiology. 303(2). 455–464. 101 indexed citations breakdown →
10.
Cao, Guang, Xiaodong Wang, Hui Chen, et al.. (2022). Hepatic arterial infusion chemotherapy plus regorafenib in advanced colorectal cancer: a real-world retrospective study. BMC Gastroenterology. 22(1). 328–328. 4 indexed citations
11.
12.
13.
Cao, Guang, Liang Xu, Xu Zhu, et al.. (2020). Retrograde embolization technique of the right gastric artery during the implantation of port-catheter system for hepatic arterial infusion chemotherapy. SHILAP Revista de lepidopterología. 4(1). 27–31. 3 indexed citations
14.
Zhang, Xin, Di Wu, Xiaoting Li, et al.. (2020). Transarterial chemoembolization with hepatic arterial infusion chemotherapy plus S-1 for hepatocellular carcinoma. World Journal of Gastroenterology. 26(27). 3975–3988. 11 indexed citations
15.
Zhu, Xu, Yina Jiang, Lida Wang, et al.. (2018). A meta-analysis of autologous transplantation for newly diagnosed multiple myeloma in the era of novel agents. Leukemia & lymphoma. 60(6). 1381–1388. 10 indexed citations
16.
Gao, Song, Hui Chen, Xiaodong Wang, et al.. (2018). Effect of primary tumor side on survival outcomes in metastatic colorectal cancer patients after hepatic arterial infusion chemotherapy. World Journal of Gastrointestinal Oncology. 10(11). 431–438. 4 indexed citations
17.
Zuo, Teng, et al.. (2017). Differential expression of hENT1 and hENT2 in colon cancer cell lines. Genetics and Molecular Research. 16(1). 11 indexed citations
18.
Kemp, David, Colin D. Brown, Guodong Han, et al.. (2011). Chinese grasslands: Problems, dilemmas and finding solutions. Charles Sturt University Research Output (CRO). 134(1). 12–24. 14 indexed citations
19.
Zhu, Xu, et al.. (2010). Changes of community structure and species diversity in different succession stages in typical steppe.. Ganhanqu ziyuan yu huanjing. 24(2). 163–169. 1 indexed citations
20.
Zhu, Xu, et al.. (2009). Influence of seasonal exclosure on plant and soil characteristics in typical steppe.. Acta Pratacultural Science. 18(2). 3–10. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xu-Dong Qu Breakdown of academic impact, for papers by Hirofumi Kamachi Breakdown of academic impact, for papers by Maria Augusta Cipriano Breakdown of academic impact, for papers by Weiqi Rong Breakdown of academic impact, for papers by Yuji Eso Breakdown of academic impact, for papers by Liming Wang Breakdown of academic impact, for papers by Kinya Okamoto Breakdown of academic impact, for papers by Chiara Caparello Breakdown of academic impact, for papers by Xavier Adhoute
Rankless by CCL
2026